ATE462975T1 - Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers - Google Patents

Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers

Info

Publication number
ATE462975T1
ATE462975T1 AT06025157T AT06025157T ATE462975T1 AT E462975 T1 ATE462975 T1 AT E462975T1 AT 06025157 T AT06025157 T AT 06025157T AT 06025157 T AT06025157 T AT 06025157T AT E462975 T1 ATE462975 T1 AT E462975T1
Authority
AT
Austria
Prior art keywords
antibody
soluble
antigen protein
immunochemical
immunochemical testing
Prior art date
Application number
AT06025157T
Other languages
English (en)
Inventor
Yasuko Ozaki
Yasuo Koishihara
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE462975T1 publication Critical patent/ATE462975T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06025157T 1998-02-25 1999-02-25 Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers ATE462975T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6061398 1998-02-25

Publications (1)

Publication Number Publication Date
ATE462975T1 true ATE462975T1 (de) 2010-04-15

Family

ID=13147307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06025157T ATE462975T1 (de) 1998-02-25 1999-02-25 Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers

Country Status (6)

Country Link
EP (2) EP1059533A4 (de)
JP (1) JP3609026B2 (de)
AT (1) ATE462975T1 (de)
AU (1) AU2640399A (de)
DE (1) DE69942215D1 (de)
WO (1) WO1999043703A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001246846A1 (en) * 2000-04-06 2001-10-23 Chugai Seiyaku Kabushiki Kaisha Immunoassay of anti-hm1.24 antibody
WO2002057316A1 (en) * 2000-12-28 2002-07-25 Kirin Beer Kabushiki Kaisha Novel monoclonal antibody
EP1378752A4 (de) * 2001-04-13 2004-08-04 Chugai Pharmaceutical Co Ltd Verfahren zur quantifizierung der antigenexpression
DE60328814D1 (de) 2002-10-30 2009-09-24 Chugai Pharmaceutical Co Ltd Hm1.24 verwertende krebsvakzine
JP4915919B2 (ja) 2004-06-11 2012-04-11 Ｓｂｉバイオテック株式会社 インターフェロン産生細胞の活性調節剤
US7740856B2 (en) 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
US8329186B2 (en) 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
US20080299128A1 (en) * 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
EP1957526B1 (de) * 2004-12-20 2013-06-26 Isu Abxis Co., Ltd. Die interzelluläre adhäsion inhibierende moleküle
CA2660795C (en) 2006-09-18 2014-11-18 Xencor, Inc. Optimized antibodies that target hm1.24
WO2021081880A1 (zh) * 2019-10-31 2021-05-06 中国科学院深圳先进技术研究院 一种杂交瘤细胞株及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
UA76934C2 (en) * 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
HUP0001136A3 (en) * 1997-02-12 2002-02-28 Chugai Pharmaceutical Co Ltd Remedies for lymphocytic tumors
KR100370744B1 (ko) * 1997-02-28 2003-02-05 츄가이 세이야꾸 가부시키가이샤 임파구의 활성화 억제제
CA2305712A1 (en) * 1997-10-03 1999-04-15 Chugai Seiyaku Kabushiki Kaisha Natural humanized antibody

Also Published As

Publication number Publication date
DE69942215D1 (de) 2010-05-12
WO1999043703A8 (fr) 1999-12-02
AU2640399A (en) 1999-09-15
EP1059533A4 (de) 2005-02-09
EP1059533A1 (de) 2000-12-13
EP1757941A1 (de) 2007-02-28
JP3609026B2 (ja) 2005-01-12
WO1999043703A1 (fr) 1999-09-02
EP1757941B1 (de) 2010-03-31

Similar Documents

Publication Publication Date Title
DE69841864D1 (de) Testvorrichtung und Verfahren zum Nachweis von Restanalyten in Proben
WO2002010754A3 (en) Assay apparatus
DE59814295D1 (de) Verfahren zur Analytbestimmung unter Verwendung eines universellen Analysenelementes
ATE113722T1 (de) Vorrichtung und verfahren zur bestimmung einer komponente einer probe.
ATE191277T1 (de) Verfahren zum nachweiss von antikörpern
NZ213959A (en) Immunoassay method for the determination of a particular protein analyte in a sample
DE60144551D1 (de) Immunologisch-analytisches Verfahren zur Bestimmung von glykosylierten Proteinen (AGEs)
ATE253645T1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
ATE125572T1 (de) Immunodiagnostisches verfahren zum nachweis und zur bestimmung von euterentzündung.
EP0383313A3 (de) Reagenz für Immuntestverfahren und Kit dieses enhaltend
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE441111T1 (de) Metallchelat-markierte peptide
PT918991E (pt) Metodo de ensaio
ATE403866T1 (de) Verfahren zum nachweis von antikörpern in flüssigen proben
ATE284034T1 (de) Verfahren zum nachweis von protein s
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
CA2366651A1 (en) A method for detecting megsin protein and use thereof
CA2213083A1 (en) Detection of antibody production
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
GR940300091T1 (en) Equipment and test for determining an antigen/antibody in a test sample.
EP0368674A3 (de) Immunoessay und dafür geeignete Testsätze

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties